Eva Hammerby

4PUBLICATIONS
3CO-AUTHORS
Infant and child healthAllergyGenetically modified treesPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 26, 2023
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.

Eckard Hamelmann, Eva Hammerby, Katrine Skaarup Scharling

|Jan 18, 2023
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis.

Anne K Ellis, Douglas P Mack, Rémi Gagnon

|Jul 09, 2021
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada.

Anne K Ellis, Rémi Gagnon, Eva Hammerby

|May 08, 2019
Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?

Anne K Ellis, Rémi Gagnon, Eva Hammerby

Pageof 1